Your browser doesn't support javascript.
loading
Reduced risk of hypoglycemia with once-daily glargine versus twice-daily NPH and number needed to harm with NPH to demonstrate the risk of one additional hypoglycemic event in type 2 diabetes: Evidence from a long-term controlled trial.
Rosenstock, Julio; Fonseca, Vivian; Schinzel, Stefan; Dain, Marie-Paule; Mullins, Peter; Riddle, Matthew.
Affiliation
  • Rosenstock J; Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX, USA. Electronic address: juliorosenstock@dallasdiabetes.com.
  • Fonseca V; Tulane University Health Sciences Center, New Orleans, LA, USA.
  • Schinzel S; Sanofi Deutschland GmbH, Frankfurt, Germany.
  • Dain MP; Sanofi, Paris, France.
  • Mullins P; Department of Statistics, University of Auckland, Auckland, New Zealand.
  • Riddle M; Oregon Health & Science University, Portland, OR, USA.
J Diabetes Complications ; 28(5): 742-9, 2014.
Article in En | MEDLINE | ID: mdl-24856612

Full text: 1 Database: MEDLINE Main subject: Insulin, Long-Acting / Diabetes Mellitus, Type 2 / Hypoglycemia / Hypoglycemic Agents / Insulin, Isophane Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Diabetes Complications Journal subject: ENDOCRINOLOGIA Year: 2014 Type: Article

Full text: 1 Database: MEDLINE Main subject: Insulin, Long-Acting / Diabetes Mellitus, Type 2 / Hypoglycemia / Hypoglycemic Agents / Insulin, Isophane Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Diabetes Complications Journal subject: ENDOCRINOLOGIA Year: 2014 Type: Article